Scrip Asks…What Does 2023 Hold For Biopharma? Part 3: Global Headwinds

Tough Times Call For Resilience, Flexibility And Collaboration

Headwinds of political instability, violent conflict, inflation and recession accompany us into 2023. Scrip surveyed industry leaders on the impacts for biopharma.

Scrip Asks Part 3
• Source: Shutterstock

For the third installment of our Scrip Asks…What Does 2023 Hold For Biopharma? series, we asked industry leaders and experts how the sector would be affected by the global headwinds of political instability, violent conflict, inflation and recession.

More from Scrip Asks

More from Scrip